Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Related posts
-
Imanaga shines, but Cubs offense snoozes in loss to Dodgers
The Cubs got off to a nice start behind pitcher Shota Imanaga in Tuesday’s season-opener in... -
Yamamoto, Ohtani deliver in return to Japan, Dodgers beat the Cubs 4-1 in season opener
Yoshinobu Yamamoto threw five strong innings, Shohei Ohtani had two hits and scored twice, and the... -
Robbery of $30,000 necklace incited wild brawl, shoot-out at O’Hare after Spirit flight
A $30,000 gold necklace caused a wild shoot-out at O’Hare Airport, where nearly 60 shots were...